Company news

SureNano Science Ltd news in 2026

SureNano Science Ltd's news releases, calls and decks from 2026, newest first.

View company

SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio

April 24, 2026

SureNano Science Ltd. Acquires GlucaPharm Inc., Advancing Second-Generation FDA Pathway GLP-1 Drug Development

February 23, 2026

Decks in 2026